DBV Technologies S.A.

DBVT | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.10

-$0.25 (-2.02%)

At close: Sep 21, 2026, 4:00 PM ET

$12.10

$0 (0.00%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.02%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $289.45M

1D Range

12 12.31

52W Range

8.86 26.19

Valuation (TTM)

PE -6.05

PB 1.80

EV/EBITDA -0.75

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $46.33

Cash Flow

FCF Yield -69.3%

SBC Adj. FCF Yield -72.5%

SBC Impact -4.5%

Margins

Gross Margin -122.2%

Operating Margin -3166.4%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -130.0% | -20.8%

Dil EPS 3Y | 5Y -39.3% | -11.3%

FCF 3Y | 5Y -36.2% | -27.8%

Returns

ROA -79.0%

ROE -119.5%

ROIC -97.3%

Financial Health

Net Cash

$167.2M

Current Ratio 3.72

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagsh...

Sector Healthcare

Industry Biotechnology

Employees 161

IPO Date Oct 21, 2014

Website www.dbv-technologies.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Oct 28, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$48

Upside

+296.69%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞